Tenofovir alafenamide fumarate 1392275-56-7
TDS
1392275-56-7
Pharmaceutical Grade
99%
Zison
Foil bag
2023-02-28
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Tenofovir alafenamide hemifumarate
Other Name:L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1);N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2-butenedioate (2:1);GS-7340 (hemifumarate);TENOFOVIR ALAFENAMIDE HEMIFUMARATE (GS-7340 HEMIFUMARATE);Tenofovir levamide amine fumarate;GS7340(Tenofovir Alafenamide Fumarate);(Tenofovir alafenamide : fumarate = 2:1);Anti-HIV
CAS No.:1392275-56-7
Molecular Formula:C25H33N6O9P
InChIKeys:MEJAFWXKUKMUIR-GQDWUREHNA-N
Molecular Weight:592.55
EC Number:805-448-8
Color/Form:White to off-white
Categories:
Characteristics-
Critical Temperature & Pressure:
Keep in dark place,Sealed in dry,Room Temperature
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
Certifications:
business license,ISO
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
